Liverpool John Moores University
ljmu.ac.ukTotal trials
73
Active
11
Phase 3
0
Total enrollment
7,183
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Caffeine | — | — | — | — | 2 | ||
| Postbiotic | — | — | — | — | — | 1 |
Next readouts
- 2026-03-25
- 2026-03-25
- 2026-07-30
Top conditions
- Physical Activity8
- Type1diabetes5
- Stress, Physiological3
- Stress, Psychological3
- Metabolic Syndrome3
- Type 1 Diabetes3
- Placebo - Control3
- No Pill3
Frequently asked questions about Liverpool John Moores University
- How many clinical trials does Liverpool John Moores University have on ClinicalTrials.gov?
- Liverpool John Moores University is listed as the lead sponsor on 73 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Liverpool John Moores University's trials are in Phase 3?
- 0 of Liverpool John Moores University's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Liverpool John Moores University focus on?
- Liverpool John Moores University's most-studied conditions on ClinicalTrials.gov are Physical Activity, Type1diabetes, Stress, Physiological, Stress, Psychological, Metabolic Syndrome.
- When are Liverpool John Moores University's next clinical trial readouts?
- Liverpool John Moores University has 3 upcoming primary-completion readouts tracked here; the soonest is “Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males”, expected around 2026-03-25.